logo

For the Inventor, By the Inventor

Kamakura, Japan

Akiko Fujiwara

USPTO Granted Patents = 17

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Kamokura, JP (1980)
  • Kamakura, JP (1980 - 1996)

Company Filing History:

goldMedal17 out of 4,948 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1980-1996

Loading Chart...
17 patents (USPTO):Explore Patents
1. 5541108 - Gluconobacter oxydans strains (1996-07-30),
2. 5352599 - Co-enzyme-independent L-sorbosone dehydrogenase of gluconobacter (1994-10-04),
3. 5085993 - Coenzyme-independent L-sorbosone dehydrogenase from Pseudomonas putida (1992-02-04),
4. 4916069 - Enzyme and process for producing the same (1990-04-10),
5. 4902617 - Enzyme and process for producing the same (1990-02-20),
6. 4472571 - Optically active anthracycline glycosides A and B (1984-09-18),
7. 4405713 - Process for the preparation of optically active anthracycline glycosides (1983-09-20),
8. 4401812 - Anthracycline antibiotics (1983-08-30),
9. 4383037 - Process to produce anthracycline glycosides (1983-05-10),
10. 4379842 - Process for the manufacture of 1.alpha.-hydroxydehydroepiandrosterone (1983-04-12),
11. 4375511 - Process to produce aclacinomycins A and B (1983-03-01),
12. 4336332 - Process for the manufacture of hydroxylated steroids (1982-06-22),
13. 4329339 - Anthracyclinones and derivatives thereof (1982-05-11),
14. 4304861 - Process of producing antibiotic SM-173B with Streptomyces chromofuscus (1981-12-08),
15. 4271268 - Process for producing D-arabitol (1981-06-02),

Title: The Innovative Contributions of Akiko Fujiwara

Introduction

Akiko Fujiwara is a notable inventor from Kamakura, Japan, who has made significant strides in the field of biotechnology. With 17 patents to her name, she has contributed to various innovations that enhance our understanding and application of microbial processes.

Latest Patents

Among her latest patents, Akiko developed a process involving Gluconobacter oxydans strains for producing 2-keto-L-gulonic acid. This process utilizes L-sorbose and/or D-sorbitol with the help of a microorganism or its cell-free extract, specifically highlighting a strain of Gluconobacter oxydans that possesses L-sorbose dehydrogenase activity. Additionally, her patent outlines specific microorganisms that are crucial to this process. Another significant innovation she has contributed to is the co-enzyme-independent L-sorbosone dehydrogenase of Gluconobacter, which further exemplifies her pioneering work in the field.

Career Highlights

Akiko Fujiwara currently works at Hoffmann-La Roche Inc., where she has been integral to various research and development projects. Her work in the company is focused on advancing microbial technology, which can have far-reaching implications in the pharmaceutical and nutritional industries.

Collaborations

Throughout her career, Akiko has collaborated with esteemed colleagues, including Tatsuo Hoshino and Masaaki Tazoe. Their combined expertise has fostered an environment of innovation, leading to groundbreaking discoveries and practical applications in her field of study.

Conclusion

Akiko Fujiwara exemplifies the spirit of innovation through her numerous patents and collaborations. Her contributions, particularly in the area of biotechnology, highlight the essential role of inventors in advancing scientific knowledge and application. As she continues her work at Hoffmann-La Roche Inc., the impact of her inventions will undoubtedly pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…